Global Vocal Biomarker Market size- Industry Trends &
Outlook Report 2026
The Global Vocal Biomarker Market size is estimated at USD 1.73
billion in 2019, and it is expected to reach USD 4.2 billion at a CAGR of 13.6
% during projection period 2020-2026. The market for Vocal Biomarker (a device
to detect diseases by speech characteristics) is dependent on the prevalence of
psychological, neurological and other diseases affecting speech and the urgency
of detection of the severe illness. Besides, its cost efficiency and early
detection of diseases drive the market growth. The market has been growing at a
steady rate over the past few years. And, it is expected to grow extensively
during the projection period. The pharmaceutical companies are exploring the
potential of the market further as they help in healthcare and drug sales. The
defence and security agencies increasingly use it as a lie-detector test.
Global Vocal Biomarker Market Overview
Recent discoveries in the medical sector have led to the
development of an exceptional diagnostic tool known as a vocal biomarker, by
linking the concept of biological markers with the vocal pattern to analyze
personality traits. Vocal Biomarker is a new medical device used to detect
diseases based on voice pattern. It is a cost-efficient and minimally invasive
technique which helps detect illnesses in the initial stage. Vocal Biomarker
finds application in detection of diseases as well as in the detection of liar
suspects. Besides medical practices, it is used by defence organizations and
security agencies while probing a defendant. It serves as a substitute for MRI,
X-Ray and CT scan in some medical urgency. The advanced uses of this technique
are likely to promote its market during the projected period.
Global Vocal Biomarker Market Outlook and Trends
Prevalence of Parkinson's Disease and other diseases induce the
demand for Vocal Biomarker
As per a study of Parkinson's Foundation, more than 10 million
across the globe suffer from Parkinson's disease. The prevalence, risk, early
detection requirement and increasing cases of this disease lead to the more
demand for vocal Biomarker, assuring strong growth potential for the market.
Besides, the rising incidence of traumatic brain injury, cardiovascular &
psychological diseases and respiratory disorders will also drive the market
during the projection period.
Growing Applications in Healthcare and Other fields
The vocal biomarkers are finding their application in remote
health monitoring of the heart-patient, in the testing voice of the patient
with coronary artery disease and recognizing depression and stress among
callers besides early detection of diseases in healthcare and lie-detection in
security agencies. Such applications are expected to amplify the market for
Accuracy Issues restrict the market growth.
The accuracy of the vocal Biomarker may vary with the use of
complex words and the environments of speech recording. Also, collection,
processing and analysis of speech data raise doubts related to its quality.
Besides, the inability to extract the desired vocal features, significant
errors in the vocal features and inaccuracies of boundaries of words also
restrict the use of vocal Biomarker, hampering its growth of the market.
Impact of COVID-19 in industry
The overall slowdown has been registered in economic activities
across the globe. However, people in every sector have learned to maintain
social distancing and to work remotely. The vocal Biomarker serves as a remote
sensor for patients with fatal diseases and helps to recognize a medical
emergency. In COVID times, its application is more relevant and is being
deployed in different countries for different medical purposes.
Global Vocal Biomarker Market: Segmentation
The Vocal Biomarker market is segmented into four categories
viz., Type, Indications, Neurological Disorders and End-user. The Type category
is divided into Frequency, Amplitude, Error Rate, Voice Rise/fall time,
Phonation Time, Voice Tremor, Pitch and Others. The Indication category is
subdivided into Depression, Attention Deficit and Disruptive Behavior Disorders
The Neurological Diseases Category is again divided into
Parkinson's Disease, Alzheimer's disease, Huntington's disease, Respiratory and
Cardiovascular Disorders, Traumatic Brain Injury and Others. The end-user
category consists of Hospitals and Clinics, Academic and Research, Others.
In the first category based on type, the voice tremor segment is
expected to register significant growth due to rising neurological disorders
and growing application of vocal Biomarker in it. In indication category of
various diseases, the respiratory diseases segment is anticipated to witness
significant growth on account of the prevalence of respiratory diseases and
ongoing research on the use of biomarkers in asthma conditions. In the end-user
segment, the healthcare sector is likely to observe more applications and more
usage of vocal Biomarker during the projection period.
Biomarker Market: Regional Insights
North America is characterized by well-established healthcare
facilities and technological advancements, so it is likely to dominate the
Global Vocal Biomarker Market during the projection period. Besides, easy
medical reimbursement policies and increasing healthcare expenditure in the
region contribute to the growth of the market. Europe is the second most
promising market driven by increasing healthcare outlay and rising income &
awareness. Asia Pacific region is expected to register growth driven by the
markets in China, India, Japan and South Korea. The Middle East and Africa
region is anticipated to register the lowest growth on account of technological
impediments and poor economic and political conditions.
The technological advancements are instilling fierce competition
among existing players in Global Vocal Biomarker Market. They are keen on
acquiring new technologies, including AI, to improve their market share. The
leading players in this market are Sonde Health(US), Beyond Verbal (Israel),
IBM Corporation (US), Cogito Corporation (US), Boston Technology Corporation,
Microtest Health and others.
August 3, 2020: Sonde
Health develops a workplace safety tool with voice biometrics. Facial
recognition, temperature recognition, wearable and voice biometrics are being
deployed COVID-19 spread prevention across the world.
December 12, 2019: Israeli
health tech firms- Beyond Verbal and Healthymize merge to advance AI-powered
Scope of the Report
data – 2016-2019
Base Year –
2020 – 2026
Revenue in USD Billion
U.S, Canada, Germany, UK,
France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South
Korea UAE, South Africa, Saudi Arabia.
By Type, Indications, Neurological Disorders
and End User
Sonde Health(US), Beyond
Verbal (Israel), IBM Corporation (US), Cogito Corporation (US), Boston
Technology Corporation, Microtest Health
By Neurological Disorders
Respiratory and Cardiovascular Disorders
Ø North America
Ø Asia Pacific
Ø Latin America
Ø Middle East & Africa
The objective of the Study:
Ø To analyze and estimate the Global Vocal Biomarker Market size, in terms of value.
Ø To examine the market segmentation carefully and estimate the
market size, in terms of value, based on the region by segmenting the Global Vocal Biomarker Market into five
regions, namely, North America, Europe, Asia Pacific, Rest of the World and
their leading countries.
Ø To outline, categorize and project the Global Vocal Biomarker Market based on the By Type,
Indications, Neurological Disorders and End User.
Ø To examine competitive developments in application areas,
technology and diverse industry usage within the Global Vocal Biomarker Market.
Ø To highlight market dynamics such as drivers, restraints,
opportunities, and challenges and their impact.
Ø To provide a detailed competitive landscape, including major
players, their strategic profiles, and market shares.
Business Questions Answered by the Report:
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client:
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis